| Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA MS Khan, KM Talha, MH Maqsood, JA Rymer, BA Borlaug, KF Docherty, ... JACC: Advances 3 (8), 101063, 2024 | | 2024 |
| Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease DZ Anjum, AN Bonde, E Fosbol, CH Garred, G Gislason, M Elmegaard, ... ESC Heart Failure, 2024 | | 2024 |
| Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT … RS von Bardeleben, MS Khan, M Geyer, T Friede, J Butler, M Diek, ... Global Cardiology 2 (2), 2024 | 1 | 2024 |
| 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II F Gustafsson, MC Petrie, J Komtebedde, V Swarup, S Winkler, ... JACC: Heart Failure, 2024 | | 2024 |
| Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials S Verma, J Butler, BA Borlaug, M Davies, DW Kitzman, SJ Shah, ... Journal of the American College of Cardiology, 2024 | 1 | 2024 |
| Semaglutide and NYHA functional class in obesity-related heart failure with preserved ejection fraction: the STEP-HFpEF program M Schou, MC Petrie, BA Borlaug, J Butler, MJ Davies, DW Kitzman, ... Journal of the American College of Cardiology, 2024 | 1 | 2024 |
| Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction JA Udell, MC Petrie, WS Jones, SD Anker, J Harrington, M Mattheus, ... Journal of the American College of Cardiology 83 (23), 2233-2246, 2024 | 4 | 2024 |
| Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the … SD Anker, T Friede, RS von Bardeleben, J Butler, MS Khan, M Diek, ... European Journal of Heart Failure, 2024 | 2 | 2024 |
| 142 The impact of ferric derisomaltose in people with heart failure with or without ischaemic heart disease in the ironman trial A Ludman, J Cleland, I Ford, F Graham, M Petrie, P Foley, V Chong, ... Heart 110 (Suppl 3), A150-A152, 2024 | | 2024 |
| 145 Machine learning for prediction of incident heart failure and heart failure hospitalisation: developlment, validation and assocation with clinical phenotypes R Nadarajah, Y Nakao, F Shuweihdi, JC Hsu, A Wahab, A Helbitz, ... Heart 110 (Suppl 3), A155-A155, 2024 | | 2024 |
| 137 Efficacy of intravenous ferric derisomaltose in hospitalised and outpatient settings: insights from ironman trial M Lee, M Petrie, N Lang, J Cleland, A Hannah, A Japp, P Donnelly, ... Heart 110 (Suppl 3), A143-A145, 2024 | | 2024 |
| Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC GMC Rosano, D Stolfo, L Anderson, M Abdelhamid, M Adamo, ... European Journal of Heart Failure, 2024 | | 2024 |
| Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial AF Hernandez, JA Udell, WS Jones, SD Anker, MC Petrie, J Harrington, ... Circulation 149 (21), 1627-1638, 2024 | 11 | 2024 |
| Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis MS Usman, DL Bhatt, I Hameed, SD Anker, AYY Cheng, AF Hernandez, ... The Lancet Diabetes & Endocrinology, 2024 | | 2024 |
| Impact of Anatomical and Viability-guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy SM Ezad, M McEntegart, M Dodd, M Didagelos, N Sidik, MLK Wa, ... Journal of the American College of Cardiology, 2024 | | 2024 |
| Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia: REALIZE-K Design and Baseline Characteristics MN Kosiborod, D Cherney, K Connelly, AS Desai, PO Guimarães, L Kuthi, ... JACC: Heart Failure, 2024 | | 2024 |
| Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program MC Petrie, BA Borlaug, J Butler, MJ Davies, DW Kitzman, SJ Shah, ... Journal of the American College of Cardiology, 2024 | 2 | 2024 |
| Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials SJ Shah, K Sharma, BA Borlaug, J Butler, M Davies, DW Kitzman, ... European Heart Journal, ehae322, 2024 | 2 | 2024 |
| Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS‐HF trial SD Solomon, JW Ostrominski, M Vaduganathan, B Claggett, PS Jhund, ... European Journal of Heart Failure, 2024 | | 2024 |
| Use of medical therapy and risk of clinical events according to frailty in heart failure patients-A real-life cohort study. JE Strange, E Fosbøl, CH Garred, M Elmegaard, C Andersson, PS Jhund, ... European Journal of Heart Failure, 2024 | | 2024 |
